MEASURABLE DISEASE AS BASELINE CRITERION FOR RESPONSE ASSESSMENT IN GLIOBLASTOMA TRIALS - A COMPARISON OF THE MRI-BASED (RANO 2.0) VERSUS PET-BASED (PET RANO 1.0) ASSESSMENT

被引:0
|
作者
Mueller, K. J. [1 ]
Forbrig, R. [2 ]
Reis, J. [2 ]
Wiegand, L. [3 ]
Barci, E. [3 ]
Kunte, S. [3 ]
Kaiser, L. [3 ]
Schoenecker, S. [4 ]
Schichor, C. [5 ]
Harter, P. [6 ]
Thon, N. [5 ]
von Baumgarten, L. [5 ]
Preusser, M. [7 ]
Albert, N. L. [3 ]
机构
[1] LMU, Univ Hosp Munich, Munich, Germany
[2] LMU Univ Hosp, Dept Neuroradiol, Munich, Germany
[3] LMU Univ Hosp, Dept Nucl Med, Munich, Germany
[4] LMU Univ Hosp, Dept Radiat Oncol, Munich, Germany
[5] LMU Univ Hosp, Dept Neurosurg, Munich, Germany
[6] LMU Univ, Ctr Neuropathol & Pr Res, Munich, Germany
[7] Med Univ Vienna, Dept Med 1, Div Oncol, Vienna, Austria
关键词
D O I
10.1093/neuonc/noae144.043
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OS01.5.A
引用
收藏
页码:V15 / V15
页数:1
相关论文
共 50 条
  • [1] MEASURABLE DISEASE AS BASELINE CRITERION FOR RESPONSE ASSESSMENT IN GLIOBLASTOMA TRIALS - A COMPARATIVE STUDY OF MRI-BASED (RANO 2.0) VERSUS PET-BASED (PET RANO 1.0) ASSESSMENT
    Mueller, Katharina Johanna
    Forbrig, Robert
    Reis, Jonas
    Wiegand, Lilian
    Barci, Enio
    Kunte, Sophie
    Kaiser, Lena
    Schoenecker, Stephan
    Schichor, Christian
    Harter, Patrick
    Thon, Niklas
    von Baumgarten, Louisa
    Preusser, Matthias
    Albert, Nathalie Lisa
    NEURO-ONCOLOGY, 2024, 26
  • [2] Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET-based (PET RANO 1.0) and MRI-based (RANO) assessments
    Mueller, Katharina J.
    Forbrig, Robert
    Reis, Jonas
    Wiegand, Lilian
    Barci, Enio
    Kunte, Sophie C.
    Kaiser, Lena
    Schoenecker, Stephan
    Schichor, Christian
    Harter, Patrick N.
    Thon, Niklas
    von Baumgarten, Louisa
    Preusser, Matthias
    Albert, Nathalie L.
    NEURO-ONCOLOGY, 2024, 27 (01) : 77 - 88
  • [3] Measurable Disease in Glioblastoma using PET-based Response Assessment in Neuro-Oncology (PET RANO 1.0)
    Harlianto, Netanja i.
    RADIOLOGY-IMAGING CANCER, 2025, 7 (01):
  • [4] PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group
    Albert, Nathalie L.
    Galldiks, Norbert
    Ellingson, Benjamin M.
    van den Bent, Martin J.
    Chang, Susan M.
    Cicone, Francesco
    de Groot, John
    Koh, Eng-Siew
    Law, Ian
    Le Rhun, Emilie
    Mair, Maximilian J.
    Minniti, Giuseppe
    Ruda, Roberta
    Scott, Andrew M.
    Short, Susan C.
    Smits, Marion
    Suchorska, Bogdana
    Tolboom, Nelleke
    Traub-Weidinger, Tatjana
    Tonn, Joerg-Christian
    Verger, Antoine
    Weller, Michael
    Wen, Patrick Y.
    Preusser, Matthias
    LANCET ONCOLOGY, 2024, 25 (01): : E29 - E41
  • [5] PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): application to18F-FDOPA PET imaging
    Stien, G.
    Zinsz, A.
    Ahrari, S.
    Taillandier, L.
    Blonski, M.
    Imbert, L.
    Timothee, Z.
    Verger, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S356 - S356
  • [6] PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): methodological application in [18F]-FDOPA PET imaging
    Guilhem Stien
    Adeline Zinsz
    Shamimeh Ahrari
    Luc Taillandier
    Marie Blonski
    Laetitia Imbert
    Timothée Zaragori
    Antoine Verger
    EJNMMI Research, 15 (1)
  • [7] Effect of MRI-based semiautomatic size-assessment in cerebral metastases on the RANO-BM classification
    Bauknecht, Hans-Christian
    Klingebiel, Randolf
    Hein, Patrick
    Wolf, Claudia
    Bornemann, Lars
    Siebert, Eberhard
    Bohner, Georg
    CLINICAL NEURORADIOLOGY, 2020, 30 (02) : 263 - 270
  • [8] Effect of MRI-based semiautomatic size-assessment in cerebral metastases on the RANO-BM classification
    Hans-Christian Bauknecht
    Randolf Klingebiel
    Patrick Hein
    Claudia Wolf
    Lars Bornemann
    Eberhard Siebert
    Georg Bohner
    Clinical Neuroradiology, 2020, 30 : 263 - 270
  • [9] Voxel clustering for quantifying PET-based treatment response assessment
    Schreibmann, Eduard
    Waller, Anthony F.
    Crocker, Ian
    Curran, Walter
    Fox, Tim
    MEDICAL PHYSICS, 2013, 40 (01)
  • [10] PET-Based Total Body Assessment of Response to Immunotherapy in Melanoma
    Moradpour, Moein
    Mhana, Sedra Abou Ali
    Rokni, Mehrad
    Al-Daoud, Omar
    Al Doori, Lana
    Werner, Thomas
    Abdelhafez, Yasser
    Alavi, Abass
    Nardo, Lorenzo
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65